Double-blind, randomized, steroid-controlled, parallel-group study of GGS in patients with optic neuritis (ON) (Phase 3 study)

Trial Profile

Double-blind, randomized, steroid-controlled, parallel-group study of GGS in patients with optic neuritis (ON) (Phase 3 study)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 May 2017

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Optic neuritis
  • Focus Therapeutic Use
  • Sponsors Teijin Pharma
  • Most Recent Events

    • 01 May 2017 Planned End Date changed from 30 Nov 2015 to 31 Aug 2018.
    • 09 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top